Generic Name: Olumiant for Alopecia (baricitinib)
Olumiant for Alopecia Reviews
"I had Alopecia Totalis, so I started using Olumiant on November 1, 2022, at a dosage of 4 mg daily. Within one year, 90% of my hair had regrown. I plan to continue this dosage until November 1, 2024, and then, in consultation with my dermatologist, we will explore the possibility of lowering the dose. Regarding side effects, the only things I can mention are a slight increase in cholesterol levels and weight gain. However, Olumiant is definitely a lifesaver. If one meets the criteria to initiate this drug, they must take it into consideration."
"I was diagnosed with alopecia areata around 37 years old. I'm 46 now. I lost almost all of my long, beautiful, thick, curly hair over about 2 years, one bald spot at a time but constantly. I started Olumiant on 8/14/23 and the results are amazing. It's a MIRACLE. Thank you to the creators. I wish you all the success and glory in the world for creating my cure."
"I've been taking Olumiant for 18 months. Great results. However, my white cells count continues to decrease. Neutropenia scares me. There's so little clinical data available on the effects of stopping the drug. I could lose my new hair growth at the base of my hairline or, Even worse, I could lose hair elsewhere - like right off the top of my head! Good grief."
"Using Olumiant for 1 1/2 years has done wonders. Hair grew back on my head and face. I have had alopecia universalis for at least 14 years. My thyroid even started rejuvenating itself. I have been taking less thyroid, and I have been on thyroid medicine for almost 40 years."
"Had to lower dosage to 1 mg. Unclear if BP has increased since being on med. Hair growth was great at 2 mg."
"So far, some progress. 2mg for about a year and increasing to 3mg. Cautious of other issues that could occur with medication as it seems when I'm on 4mg I have some issues."
More about Olumiant (baricitinib)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (14)
- Drug images
- Latest FDA alerts (1)
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- FDA approval history
- Drug class: antirheumatics
- Breastfeeding
- En español
Patient resources
- Olumiant drug information
Professional resources
- Olumiant prescribing information
- Baricitinib (AHFS Monograph)
Related treatment guides
- Alopecia
- Rheumatoid Arthritis
- COVID-19
